Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
Development of COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial across all adult age groups
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
Gileadﾒs investigational antiviral Vekluryﾮ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
Vaccitech received government grant for COVID-19 vaccine research
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
Biotechnology | COVID-19 | Diagnostics | NIH
White House announced plan to deploy 150 million rapid tests in 2020
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
RedHill Biopharma Announced Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use Authorization
On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWﾙ COVID-19…
UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidate
On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
Heat Biologics’ announced publication of preclinical COVID-19 vaccine results
On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…
Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
How SARS-CoV-2 spread across greater Boston during pandemic’s first wave
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
COVID-19 drug candidate Brilacidin achieved a selectivity index among the highest reported
On Aug. 24, 2020, Innovation Pharma reported receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL) based…
Genomic analysis revealed many animal species may be vulnerable to SARS-CoV-2 infection
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
Quest Diagnostics Foundation launched initiative to reduce health disparities in underserved communities
On Aug. 24, 2020, the Quest Diagnostics Foundation announced a wide-ranging initiative to address and reduce health disparities…
Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
AXIM Biotechnologies signed exclusive licensing, manufacturing and distribution agreement for production of COVID-19 rapid neutralizing antibody test
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…